No Data
Leerink Partners Maintains AstraZeneca(AZN.US) With Buy Rating
AstraZeneca's Strong EPS Performance and Strategic Developments Justify Buy Rating
BofA Securities Keeps AstraZeneca at Buy as Q1 EPS Tops Consensus
AstraZeneca's Earnings Call: Strong Growth Amid Challenges
Overview of international financial hotspots from last night and this morning _ April 30, 2025 _ Financial news.
For more global financial News, please move to the 7×24 hours real-time financial news. Market closing: The Dow Jones and S&P indices have risen for six consecutive days, with the market focusing on trade negotiation progress. On April 29, the top 20 trading volumes in US stocks: Amazon exposed tariff costs and was criticized by the White House. On Tuesday, China Concept Stocks were mixed, with New Oriental up 4.07% and Xpeng Autos down 6.32%. The shadow of the trade war looms, with international oil prices hitting a two-week low. Spot Gold fell over 0.7%, momentarily dropping below $3,300. Major European stock indices closed with gains, with the German DAX30 Index initially rising by 0.76%. Macro Goldman Sachs significantly lowered the GDP growth rate for the USA in the first quarter to -.
What Does the Market Think About AstraZeneca?
